{"id":240368,"date":"2018-07-12T05:56:02","date_gmt":"2018-07-12T05:56:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=240368"},"modified":"2018-07-12T05:56:02","modified_gmt":"2018-07-12T05:56:02","slug":"alopecia-therapeutics-pipeline-analysis-2018","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/alopecia-therapeutics-pipeline-analysis-2018_240368.html","title":{"rendered":"Alopecia Therapeutics &#8211; Pipeline Analysis 2018."},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/07\/1435889040.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/07\/1435889040.png\" alt=\"\" width=\"225\" height=\"\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;\\&#8221;Alopecia Market\\&#8221;&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">WiseGuyReports.com adds \u201cAlopecia Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting \u201d reports to its database.<\/div>\n<p><strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/sample-request\/3271729-alopecia-pipeline-analysis-2018\">Alopecia Market<\/a><\/strong><strong>:<\/strong><\/p>\n<p><strong>Executive Summary<\/strong><\/p>\n<p>The comprehensive list of alopecia drugs that are in development. The main objective of this report is to provide a comprehensive secondary research and market analysis of alopecia pipeline products that are in Phase 3, Phase 2, Phase 1, preclinical and discovery across different indications. This report also provides comprehensive research on the companies that are working on alopecia including the deals and acquisitions.<\/p>\n<p>Report Coverage:<\/p>\n<p>Clinical (Phase Products)<\/p>\n<p>Non-clinical (Preclinical and Discovery)<\/p>\n<p>Dormant and Discontinued<\/p>\n<p><strong>Companies Mentioned<\/strong><\/p>\n<p>Concert Pharmaceuticals, Samumed, RepliCel, kerastem<\/p>\n<p><strong>Request Sample Report @ <a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/sample-request\/3271729-alopecia-pipeline-analysis-2018\">https:\/\/www.wiseguyreports.com\/sample-request\/3271729-alopecia-pipeline-analysis-2018<\/a> <\/strong><\/p>\n<p><strong>Table of Contents<\/strong><\/p>\n<p>Executive Summary&nbsp;<br \/> Overview of Alopecia&nbsp;<br \/> Recent Trends&nbsp;<br \/> Pipeline Therapeutics&nbsp;<br \/> Therapeutics under Development by Companies&nbsp;<br \/> Late State Products&nbsp;<br \/> Product Description&nbsp;<br \/> Research and Development&nbsp;<br \/> Product Development Activities<\/p>\n<p><strong>Mid Stage Products<\/strong>&nbsp;<br \/> Product Description&nbsp;<br \/> Research and Development&nbsp;<br \/> Product Development Activities<\/p>\n<p><strong>Early Stage Products<\/strong>&nbsp;<br \/> Product Description&nbsp;<br \/> Research and Development&nbsp;<br \/> Product Development Activities<\/p>\n<p><strong>Therapeutic Assessment&nbsp;<\/strong><br \/> Assessment by Route of Administration&nbsp;<br \/> Assessment by Phase &amp; Route of Administration&nbsp;<br \/> Assessment by Molecule Type&nbsp;<br \/> Assessment by Phase &amp; Molecule type&nbsp;<br \/> Collaborations and Acquisitions Details&nbsp;<br \/> Dormant Products&nbsp;<br \/> Discontinued Products&nbsp;<br \/> Appendix&nbsp;<br \/> Methodology<\/p>\n<p> Disclaimer&nbsp;<br \/> Table 1: Treatment algorithm for alopecia&nbsp;<br \/> Table 2: Products Under Development for Alopecia, 2018&nbsp;<br \/> Table 3: Products under Development by Companies, 2018&nbsp;<br \/> Table 4: Late Stage Products, 2018&nbsp;<br \/> Table 5: Mid Stage Products, 2018&nbsp;<br \/> Table 6: Early Stage Products, 2018&nbsp;<br \/> Table 7: Pre-Clinical and Discovery Products, 2018&nbsp;<br \/> Table 8: Assessment by Route of Administration, 2018&nbsp;<br \/> Table 9: Assessment by Stage and Route of Administration, 2018&nbsp;<br \/> Table 10: Assessment by Molecule Type, 2018&nbsp;<br \/> Table 11: Assessment by Stage and Molecule Type, 2018&nbsp;<br \/> Table 12: Comparative Analysis&nbsp;<br \/> Table 13: Dormant Products&nbsp;<br \/> Table 14: Discontinued Products&nbsp;<br \/> Figure 1: Treatment algorithm for alopecia&nbsp;<br \/> Figure 2: Products Under Development for Alopecia, 2018&nbsp;<br \/> Figure 3: Products under Development by Companies, 2018&nbsp;<br \/> Figure 4: Late Stage Products, 2018&nbsp;<br \/> Figure 5: Mid Stage Products, 2018&nbsp;<br \/> Figure 6: Early Stage Products, 2018&nbsp;<br \/> Figure 7: Pre-Clinical and Discovery Products, 2018&nbsp;<br \/> Figure 8: Assessment by Route of Administration, 2018&nbsp;<br \/> Figure 9: Assessment by Stage and Route of Administration, 2018&nbsp;<br \/> Figure 10: Assessment by Molecule Type, 2018&nbsp;<br \/> Figure 11: Assessment by Stage and Molecule Type, 2018&nbsp;<br \/> Figure 12: Comparative Analysis&nbsp;<br \/> Figure 13: Dormant Products&nbsp;<br \/> Figure 14: Discontinued Products&nbsp;&nbsp;<\/p>\n<p><strong>Continuous&hellip;<\/strong><\/p>\n<p><strong>For further information on this report, visit &ndash;<\/strong> <strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/reports\/3271729-alopecia-pipeline-analysis-2018\">https:\/\/www.wiseguyreports.com\/reports\/3271729-alopecia-pipeline-analysis-2018<\/a><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Wiseguyreports.com<br \/><strong>Contact Person:<\/strong> Norah Trent<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=alopecia-therapeutics-pipeline-analysis-2018&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9349, +44 208 133 9349<br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.wiseguyreports.com\" target=\"_blank\" rel=\"nofollow\">www.wiseguyreports.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.wiseguyreports.com\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=alopecia-therapeutics-pipeline-analysis-2018\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;\\&#8221;Alopecia Market\\&#8221;&#8221; WiseGuyReports.com adds \u201cAlopecia Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting \u201d reports to its database. Alopecia Market: Executive Summary The comprehensive list of alopecia drugs that are in development. The main objective of this &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/alopecia-therapeutics-pipeline-analysis-2018_240368.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-240368","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/240368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=240368"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/240368\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=240368"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=240368"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=240368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}